Search for: "Janssen Research "
Results 21 - 40
of 202
Sort by Relevance
|
Sort by Date
25 Jul 2018, 5:00 am
A plaintiff has alleged severe bleeding from Xarelto in a lawsuit against the manufacturer Janssen Research & Development and Johnson & Johnson. [read post]
15 Jun 2018, 5:00 am
More than 450,000 prescriptions for Invokana are filled every three months in the United States and the drug is marketed by Janssen Pharmaceuticals, a partner of Johnson and Johnson. [read post]
3 Apr 2018, 5:00 am
” The plaintiff claims that Xarelto was inadequately researched and over-promoted, leading to his severe injuries. [read post]
29 Mar 2018, 11:39 am
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
29 Mar 2018, 11:39 am
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
9 Mar 2018, 5:00 am
One study, says the review, had to be discarded because of research flaws. [read post]
5 Mar 2018, 4:25 pm
This variation, researchers say, isn’t explained away by weather, years of exposure, changes in vehicle density or the economy. [read post]
5 Mar 2018, 4:25 pm
This variation, researchers say, isn’t explained away by weather, years of exposure, changes in vehicle density or the economy. [read post]
5 Mar 2018, 5:00 am
The plaintiff, who is representing the deceased individual, alleges that Xarelto manufacturer Janssen Research and Development knew about severe bleeding risks but failed to warn the public and medical community about the dangers. [read post]
20 Feb 2018, 5:00 am
” Violations included discarding medical records, unauthorized unblinding, and even falsification of research records, according to the complaint. [read post]
29 Jan 2018, 5:00 am
Janssen Research & Development, Case No. 2:17-cv-17835, in the U.S. [read post]
23 Jan 2018, 5:00 am
But, alleges the lawsuit, research shows that Xarelto is safer and more effective if taken twice a day and while patients are undergoing blood monitoring. [read post]
19 Jan 2018, 12:28 pm
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
19 Jan 2018, 12:28 pm
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
17 Jan 2018, 5:00 am
Janssen Research and Developments LLC, et al., Case No. 2:17-cv-17526, in the U.S. [read post]
16 Jan 2018, 5:00 am
Other experts in child psychiatry expressed concern over the discovery of alleged research misconduct on behalf of Janssen. [read post]
11 Jan 2018, 5:00 am
Drug manufacturers and distributors hit with opioid lawsuits include: Purdue Teva/Cephalon Janssen Endo Actavis Mallinckrodt McKesson Corporation AmerisourceBergen Corporation Cardinal Health Inc. [read post]
11 Jan 2018, 5:00 am
Janssen Research & Development LLC, et al., Case No. 2:17-cv-17468, in the U.S. [read post]
5 Jan 2018, 12:00 pm
Categories: SGLT-2 Inhibitors Diabetes Drugs Hepatitis C Treatment Drugs Anticoagulants / Bloodthinners Breast Implants Osteoporosis Treatment Drugs Erectile Dysfunction (ED) Drugs Heartburn / Acid Reflux Drugs Multiple Sclerosis (MS) Treatment Drugs DPP-4 Inhibitors Diabetes Drugs Miscellaneous SGLT-2 Inhibitors Diabetes Drugs: Jardiance - Amputations Drug Safety Issue Remains Uncertain Due To Admitted "inherent limitations of... post hoc analyses" (11/28/17) Medical… [read post]
5 Jan 2018, 5:00 am
Johnson and Johnson’s Janssen Pharmaceuticals and Bayer Health Care market Xarelto and together they shared the news of the failed phase three study in a press release last October. [read post]
